بررسی تغییرات بیان lncRNA UCA1 و ژن هدف AKT تنظی مکننده مسیر سیگنالی PI3K / AKT در رده سلولی لوسمی حاد لنفوبلاستیک Jurkat E6.1 تحت تیمار با کمپلک سهای تیوسمی کاربازون

[1] Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic
leukemia. Pediatr Clin North Am. 2015; 62(1):61-73.
[DOI:10.1016/j.pcl.2014.09.006] [PMID] [PMCID]
[2] Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME,
Sather HN, et al. Long-term results of the children’s cancer group
studies for childhood acute lymphoblastic leukemia 1983–2002:
A children’s oncology group report. Leukemia. 2010; 24(2):285-
97. [DOI:10.1038/leu.2009.262] [PMID] [PMCID]
[3] Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia.
Lancet. 2013; 381(9881):1943-55. [DOI:10.1016/
S0140-6736(12)62187-4]
[4] Vrooman LM, Silverman LB. Treatment of childhood acute
lymphoblastic leukemia: Prognostic factors and clinical
advances. Curr Hematol Malig Rep. 2016; 11(5):385-94.
[DOI:10.1007/s11899-016-0337-y]
[5] Bongiovanni D, Saccomani V, Piovan E. Aberrant signaling
pathways in T-cell acute lymphoblastic leukemia. Int J Mol Sci.
2017; 18(9):1904. [DOI:10.3390/ijms18091904] [PMID] [PMCID]
[6] Belver L, Ferrando A. The genetics and mechanisms of T
cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;
16(8):494-507. [DOI:10.1038/nrc.2016.63] [PMID]
[7] Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB,
Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in
human T cell acute lymphoblastic leukemia. Science. 2004;
306(5694):269-71. [DOI:10.1126/science.1102160] [PMID]
[8] Askari R, Ranjbar M, Nakhaeizadeh M, Sheikholeslami S, Sepehrifar
S, Adhami M, e al. Survival rate of patients with acute
leukemia in Iran: A systematic review and meta-analysis.
Evid Based Health Policy Manag and Econ. 2018; 2(4):281-9.
[DOI:10.18502/jebhpme.v2i4.280]
[9] Berninghausen O, Leippe M. Necrosis versus apoptosis as the
mechanism of target cell death induced by Entamoeba histolytica.
Infect Immun. 1997; 65(9):3615-21. [DOI:10.1128/
iai.65.9.3615-3621.1997] [PMID] [PMCID]
[10] Lu M, Wang J, Ives HE, Pearce D. mSIN1 protein mediates
SGK1 protein interaction with mTORC2 protein complex and is
required for selective activation of the epithelial sodium channel.
J Biol Chem. 2011; 286(35):30647-54. [DOI:10.1074/jbc.
M111.257592] [PMID] [PMCID]
[11] Micale MA. Pediatric T-cell acute lymphoblastic leukemia.
Atlas Genet Cytogenet Oncol Haematol. 2018; (11).
[DOI:10.4267/2042/68970]
[12] Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase–AKT
pathway in human cancer. Nat Rev Cancer. 2002; 2(7):489-501.
[DOI:10.1038/nrc839] [PMID]
[13] Osaki M, Oshimura MA, Ito H. PI3K-Akt pathway: Its functions
and alterations in human cancer. Apoptosis. 2004; 9(6):667-76.
[DOI:10.1023/B:APPT.0000045801.15585.dd] [PMID]
[14] Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt:
Implications for cancer therapy. Pharmacol Ther. 2002; 93(2-
3):243-51. [DOI:10.1016/S0163-7258(02)00193-6]
[15] Nicholson KM, Anderson NG. The protein kinase B/Akt signalling
pathway in human malignancy. Cell Signal. 2002;
14(5):381-95. [DOI:10.1016/S0898-6568(01)00271-6]
[16] Shukla S, MacLennan GT, Hartman DJ, Fu P, Resnick MI, Gupta
S. Activation of PI3K‐Akt signaling pathway promotes prostate
cancer cell invasion. Int J Cancer. 2007; 121(7):1424-32.
[DOI:10.1002/ijc.22862] [PMID]
[17] Ma L, Bajic VB, Zhang Z. On the classification of long noncoding
RNAs. RNA Biol. 2013; 10(6):925-33. [DOI:10.4161/
rna.24604] [PMID] [PMCID]
[18] Clark MB, Mattick JS. Long noncoding RNAs in cell biology.
Semin Cell Dev Biol. 2011; 22(4):366-76 [DOI:10.1016/j.semcdb.
2011.01.001] [PMID]
[19] Ponting CP, Oliver PL, Reik W. Evolution and functions of long
noncoding RNAs. Cell. 2009; 136(4):629-41. [DOI:10.1016/j.
cell.2009.02.006] [PMID]
[20] Ransohoff JD, Wei Y, Khavari PA. The functions and unique
features of long intergenic non-coding RNA. Nat Rev Mol Cell
Biol. 2018; 19(3):143-57. [DOI:10.1038/nrm.2017.104] [PMID]
[PMCID]
[21] Wapinski O, Chang HY. Long noncoding RNAs and human
disease. Trends Cell Biol. 2011; 21(6):354-61. [DOI:10.1016/j.
tcb.2011.04.001] [PMID]
[22] Edgar R, Domrachev M, Lash AE. Gene expression omnibus:
NCBI gene expression and hybridization array data repository.
Nucleic Acids Res. 2002; 30(1):207-10. [DOI:10.1093/
nar/30.1.207] [PMID] [PMCID]
[23] Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, et al. Long
non-coding RNA UCA1 promotes breast tumor growth by
suppression of p27 (Kip1). Cell Death Dis. 2014; 5(1):e1008.
[DOI:10.1038/cddis.2013.541] [PMID] [PMCID]
[24] Wang H, Guan Z, He K, Qian J, Cao J, Teng L. LncRNA UCA1
in anti-cancer drug resistance. Oncotarget. 2017; 8(38):64638-
50. [DOI:10.18632/oncotarget.18344] [PMID] [PMCID]
[25] Ke Z, Tang R, Tan J, Jiang Z, Liang Z, Feng S. [Clinical observation
of clarithromycin treatment for nasosinusitis after nasopharyngeal
carcinoma radiotherapy (Chinese)]. Lin Chung Er Bi
Yan Hou Tou Jing Wai Ke Za Zhi. 2010; 24(7):299-300. [PMID]
[26] Li C, Liang G, Yang S, Sui J, Yao W, Shen X, et al. Dysregulated
lncRNA-UCA1 contributes to the progression of gastric cancer
through regulation of the PI3K-Akt-mTOR signaling pathway.
Oncotarget. 2017; 8(55):93476-91. [DOI:10.18632/oncotarget.
19281] [PMID] [PMCID]
[27] Qin L, Jia Z, Xie D, Liu Z. Retracted: Knockdown of long noncoding
RNA urothelial carcinoma–associated 1 inhibits cell
viability, migration, and invasion by regulating microRNA‐182
in gastric carcinoma. J Cell Biochem. 2018; 119(12):10075-86.
[DOI:10.1002/jcb.27344] [PMID]
[28] Ghiam AF, Taeb S, Huang X, Huang V, Ray J, Scarcello S, et
al. Long non-coding RNA urothelial carcinoma associated 1
(UCA1) mediates radiation response in prostate cancer. Oncotarget.
2017; 8(3):4668-89. [DOI:10.18632/oncotarget.13576]
[PMID] [PMCID]
Daneshi F, et al. Thiosemi Carbazon Complexes Effects on UCA1 lncRNA and AKT Target, Gene Expression Alternations, Regulating PI3K / AKT Signaling Pathway. JSMJ. 2021; 20(5):424-435.
435
Dec 2021, Jan 2022. Volume 20. Number 5
[29] Marill JL, Miller N, Kitendaugh P. The MedlinePlus public user
interface: Studies of design challenges and opportunities. J
Med Libr Assoc. 2006; 94(1):30-40. [PMCID]
[30] Sun J, Zhao R, Zeng J, Li G, Li X. Characterization of destrins
with different dextrose equivalents. Molecules. 2010;
15(8):5162-73. [DOI:10.3390/molecules15085162] [PMID]
[PMCID]
[31] Livak KJ, Schmittgen TD. Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method. Methods. 2001; 25(4):402-8. [DOI:10.1006/
meth.2001.1262] [PMID]
[32] Yao F, Wang Q, Wu Q. The prognostic value and mechanisms
of lncRNA UCA1 in human cancer. Cancer Manag Res. 2019;
11:7685-96. [DOI:10.2147/CMAR.S200436] [PMID] [PMCID]
[33] Lan A, Du J. Potential role of Akt signaling in chronic kidney
disease. Nephrol Dial Transplant. 2015; 30(3):385-94.
[DOI:10.1093/ndt/gfu196] [PMID]
[34] Revathidevi S, Munirajan AK. Akt in cancer: Mediator and
more. Semin Cancer Biol. 2019; 59:80-91. [DOI:10.1016/j.semcancer.
2019.06.002] [PMID]
[35] Song M, Bode AM, Dong Z, Lee MH. AKT as a therapeutic
target for cancer. Cancer Res. 2019; 79(6):1019-31.
[DOI:10.1158/0008-5472.CAN-18-2738] [PMID]
[36] Reis DC, Pinto MC, Souza-Fagundes EM, Wardell SM, Wardell
JL, Beraldo H. Antimony (III) complexes with 2-benzoylpyridine-
derived thiosemicarbazones: Cytotoxicity against human
leukemia cell lines. Eur J Med Chem. 2010; 45(9):3904-10.
[DOI:10.1016/j.ejmech.2010.05.044] [PMID]